A Bioavailability Study Comparing 3 Different AZD1981 Tablets
NCT01311635
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AZD1981, current small-particle tablet
DRUG:
AZD1981, new small-particle tablet
DRUG:
AZD1981, new large-particle table
Sponsor
AstraZeneca